Prescription Orthopedic Drugs Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#What Is the Estimated Market Size of the Prescription Orthopedic Drugs Market In 2029?#_x000D_
The market for prescription orthopedic medications has seen robust expansion in the past few years. The market is projected to rise from $48.41 billion in 2024 to $51.06 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this progress during the historic period include an upsurge in musculoskeletal disorders, an aging population, heightened awareness about treatments for osteoporosis, extended healthcare coverage in emerging regions, and a global rise in sports-related injuries._x000D_
_x000D_
The market for prescription orthopedic drugs is anticipated to register significant growth in the approaching years. It is forecasted to hit a value of $63.86 billion in 2029, expanding at a compound annual growth rate (CAGR) of 5.8%. The propelling factors for this growth during the forecast period might be the escalating demand for biologics, growing elderly population, wider healthcare accessibility in budding markets, an increased occurrence of long-term musculoskeletal disorders, and augmented investment in orthopedic drug R&D. The pivotal trends speculated for the forecast period encompass evolvements in targeted biologics, acceptance of regenerative medicine therapies, customization of drug formulations, strides in minimally intrusive delivery techniques, heightened efficacy of drugs through gene therapy, advancements in injectable formulas, and the use of artificial intelligence in drug creation and clinical judgement-making processes._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp_x000D_
_x000D_
#How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePrescription Orthopedic Drugs Market?#_x000D_
The growing prevalence of musculoskeletal disorders is likely to stimulate the prescription orthopedic drugs market’s expansion. These disorders, termed as MSDs, emerge as injuries or conditions hindering the functioning and movement of the body’s elements such as muscles, nerves, ligaments, tendons, and joints, causing a decrease in mobility and pain. This surge in musculoskeletal disorders can be mainly attributed to factors including aging, repetitive motions and improper postures during work, poor nutritional habits, lack of physical activity, and genetic tendencies. Prescription orthopedic drugs play a crucial role in the management of these disorders by alleviating pain, reducing inflammation, speeding up the healing process and eventually enhancing mobility and the overall life quality. For example, the Office for Health Improvement and Disparities, a department for public health based in UK, outlined in March 2023 that the percentage of people aged 16 and over dealing with long-term musculoskeletal conditions like arthritis or persistent back or joint issues increased to 17.6% in 2022 from 17.0% in 2021. Moreover, the World Health Organization, an intergovernmental organization headquartered in Switzerland, revealed in July 2022 that about 1.71 billion people globally are grappling with musculoskeletal disorders. Thus, it is evident that the escalating prevalence of musculoskeletal disorders is propelling the growth of the prescription orthopedic drugs market._x000D_
_x000D_
#Which Segments in the Prescription Orthopedic Drugs Offer the Most Growth?#_x000D_
The prescription orthopedic drugs market covered in this report is segmented – _x000D_
_x000D_
1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types_x000D_
2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications_x000D_
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_
_x000D_
Subsegments:_x000D_
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin _x000D_
2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol _x000D_
3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone _x000D_
4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine _x000D_
5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=21263&type=smp_x000D_
_x000D_
#What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePrescription Orthopedic Drugs Market?# Market?#_x000D_
North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#What Are the Current Market Growth and Trends in the Prescription Orthopedic Drugs Industry?#_x000D_
Leading corporations in the prescription orthopedic drugs market are prioritizing the expansion of their drug indications to widen their market influence, improve patient results, and cater to unfulfilled healthcare requirements in diverse orthopedic conditions. For example, Heron Therapeutics Inc., an American biotech firm, obtained FDA authorization for the broader use of ZYNRELEF (comprising bupivacaine and meloxicam) in soft tissue and orthopedic procedures, like foot and ankle surgeries, in January 2023. This long-lasting solution is specifically created to offer sustained pain relief for up to 72 hours, decreasing or completely removing the necessity for opioids post-surgery. The wider indication now encompasses further orthopedic and soft tissues surgeries, including foot and ankle surgeries, enlarging its clinical pertinence. Its novel dual-drug blend provides both anesthetic and anti-inflammatory benefits, making it an all-round choice for handling post-operative pain with improved patient results._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#What Are the Key Elements That Define the Prescription Orthopedic Drugs Market?#_x000D_
Prescription orthopedic drugs refer to medications specifically prescribed to manage conditions affecting the musculoskeletal system, such as bones, joints, muscles, and ligaments. They are used for pain relief, inflammation reduction, and promoting healing in orthopedic injuries or disorders like arthritis, fractures, and tendonitis._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21263_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Europe +44 7882 955267_x000D_
Asia & Others +44 7882 955267 & +91 8897263534_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
